| Date | Time | Source | Headline | Symbol | Company |
| 01/17/2019 | 3:00AM | PR Newswire (US) | Asceneuron Appoints Peter Van Vlasselaer as Chairman | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 01/17/2019 | 3:00AM | PR Newswire (US) | Asceneuron Appoints Peter Van Vlasselaer as Chairman | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 07/02/2018 | 3:49PM | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 6:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 4:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 4:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 4:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 4:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 4:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 4:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 4:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 4:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 4:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 4:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 8:13AM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 8:03AM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 7:59AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 7:54AM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 7:48AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/22/2018 | 7:31AM | PR Newswire (US) | Lilly Completes Acquisition of ARMO BioSciences | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/18/2018 | 4:06PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/15/2018 | 4:04PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/15/2018 | 3:27PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 06/11/2018 | 7:31AM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 05/30/2018 | 4:05PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 05/30/2018 | 4:03PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 05/23/2018 | 8:18AM | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 05/23/2018 | 7:49AM | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 05/15/2018 | 3:52PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 05/14/2018 | 10:38AM | PR Newswire (US) | WeissLaw LLP: ARMO BioSciences Inc. Acquisition May Not Be In The Best Interests of ARMO shareholders | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |